- Home
- ATAI vs ISPR Comparison
ATAI vs ISPR Comparison
Compare ATAI & ISPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATAI | ISPR |
|---|---|---|
| Founded | 2018 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 99.1M |
| IPO Year | 2021 | 2023 |
Fundamental Metrics
Financial Performance| Metric | ATAI | ISPR |
|---|---|---|
| Price | $3.77 | $1.79 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 1 |
| Target Price | ★ $15.13 | $7.50 |
| AVG Volume (30 Days) | ★ 3.5M | 151.9K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $308,000.00 | ★ $127,494,304.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $14.31 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.20 | $1.44 |
| 52 Week High | $6.73 | $3.87 |
Technical Indicators
Market Signals| Indicator | ATAI | ISPR |
|---|---|---|
| Relative Strength Index (RSI) | 53.29 | 44.66 |
| Support Level | $3.57 | $1.63 |
| Resistance Level | $4.30 | $2.70 |
| Average True Range (ATR) | 0.21 | 0.18 |
| MACD | 0.04 | 0.03 |
| Stochastic Oscillator | 70.92 | 39.48 |
Price Performance
Historical ComparisonAbout ATAI ATAI Life Sciences N.V.
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
About ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping products in the United States, Europe, Canada, and South Africa. Geographically, the company generates the majority of its revenue from Europe.